JP2019518050A5 - - Google Patents

Download PDF

Info

Publication number
JP2019518050A5
JP2019518050A5 JP2018565691A JP2018565691A JP2019518050A5 JP 2019518050 A5 JP2019518050 A5 JP 2019518050A5 JP 2018565691 A JP2018565691 A JP 2018565691A JP 2018565691 A JP2018565691 A JP 2018565691A JP 2019518050 A5 JP2019518050 A5 JP 2019518050A5
Authority
JP
Japan
Prior art keywords
ring
alkyl
compound
substituted
optionally
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2018565691A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019518050A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2017/064654 external-priority patent/WO2017216283A1/en
Publication of JP2019518050A publication Critical patent/JP2019518050A/ja
Publication of JP2019518050A5 publication Critical patent/JP2019518050A5/ja
Pending legal-status Critical Current

Links

JP2018565691A 2016-06-16 2017-06-15 抗菌薬としての複素環式化合物 Pending JP2019518050A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP16174722 2016-06-16
EP16174722.5 2016-06-16
PCT/EP2017/064654 WO2017216283A1 (en) 2016-06-16 2017-06-15 Heterocyclic compounds as antibacte rials

Publications (2)

Publication Number Publication Date
JP2019518050A JP2019518050A (ja) 2019-06-27
JP2019518050A5 true JP2019518050A5 (enExample) 2020-08-13

Family

ID=56132839

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018565691A Pending JP2019518050A (ja) 2016-06-16 2017-06-15 抗菌薬としての複素環式化合物

Country Status (12)

Country Link
US (1) US20200308169A1 (enExample)
EP (1) EP3472152A1 (enExample)
JP (1) JP2019518050A (enExample)
KR (1) KR20190018681A (enExample)
CN (1) CN109415349A (enExample)
AU (1) AU2017286370B2 (enExample)
BR (1) BR112018075939A2 (enExample)
CA (1) CA3025727A1 (enExample)
EA (1) EA201990044A1 (enExample)
MA (1) MA45375A (enExample)
MX (1) MX2018015657A (enExample)
WO (1) WO2017216283A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20220339T1 (hr) 2015-07-02 2022-05-13 Janssen Sciences Ireland Unlimited Company Antibakterijski spojevi
IL257743B (en) 2015-09-17 2022-08-01 Marvin J Miller Benzyl amine-containing heterocyclic compounds and compositions useful against mycobacterial infection
AU2017286368B2 (en) 2016-06-16 2021-02-25 Janssen Sciences Ireland Unlimited Company Heterocyclic compounds as antibacterials
EP3589323B1 (en) 2017-03-01 2024-04-03 Janssen Sciences Ireland Unlimited Company Combination therapy for the treatment of tuberculosis
TWI861208B (zh) 2019-09-10 2024-11-11 日商鹽野義製藥股份有限公司 對分枝桿菌感染有用之含苄胺的 5,6-雜芳族化合物
CN114423758B (zh) * 2019-09-13 2025-05-27 爱尔兰詹森科学公司 抗细菌化合物
EP4038067A1 (en) 2019-09-30 2022-08-10 Janssen Sciences Ireland Unlimited Company 4-quinolinone antibacterial compounds
WO2021063915A1 (en) 2019-09-30 2021-04-08 Janssen Sciences Ireland Unlimited Company Antibacterial compounds
AU2022237769A1 (en) 2021-03-16 2023-11-02 Janssen Sciences Ireland Unlimited Company Antibacterial compounds
WO2022194905A1 (en) 2021-03-17 2022-09-22 Janssen Sciences Ireland Unlimited Company Antibacterial compounds
EP4308579A1 (en) 2021-03-17 2024-01-24 Janssen Sciences Ireland Unlimited Company Antibacterial compounds
WO2022214520A1 (en) 2021-04-07 2022-10-13 Janssen Sciences Ireland Unlimited Company Antibacterial compounds
WO2022214519A1 (en) 2021-04-07 2022-10-13 Janssen Sciences Ireland Unlimited Company Antibacterial compounds
KR20240090864A (ko) 2021-10-28 2024-06-21 얀센 사이언시즈 아일랜드 언리미티드 컴퍼니 세균성 감염의 치료에 사용하기 위한 이미다조피리딘 아미드 및 관련 화합물
WO2024089170A1 (en) 2022-10-27 2024-05-02 Janssen Sciences Ireland Unlimited Company Antibacterial compounds
WO2024223859A1 (en) 2023-04-26 2024-10-31 Janssen Pharmaceutica Nv Antibacterial compounds

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA008937B1 (ru) 2002-07-25 2007-10-26 Янссен Фармацевтика Н.В. Производные хинолина и их применение в качестве микобактериальных ингибиторов
EP3257854A1 (en) * 2009-11-05 2017-12-20 University of Notre Dame du Lac Imidazo[1,2-a]pyridine compounds, synthesis thereof, and methods of using same
MX345762B (es) 2010-03-18 2017-02-15 Pasteur Institut Korea Compuestos antiinfecciosos.
US9199981B2 (en) 2011-09-01 2015-12-01 Novartis Ag Compounds and compositions as C-kit kinase inhibitors
AP2014007493A0 (en) 2011-09-01 2014-03-31 Irm Llc Compounds and compositions as C-KIT kinase inhibitors
EP2875029B8 (en) * 2012-07-18 2021-12-15 University of Notre Dame du Lac 5,5-heteroaromatic anti-infective compounds
WO2015014993A2 (en) * 2013-08-02 2015-02-05 Institut Pasteur Korea Anti-infective compounds
CN105524058B (zh) * 2014-10-21 2018-03-27 广州艾格生物科技有限公司 吡唑并[1,5‑a]吡啶类化合物及其应用

Similar Documents

Publication Publication Date Title
JP2019518050A5 (enExample)
JP2019518046A5 (enExample)
JP2018519302A5 (enExample)
JP2018524339A5 (enExample)
JP2020169171A5 (enExample)
JP2019526596A5 (enExample)
JP2017524025A5 (enExample)
JP2014500295A5 (enExample)
JP2016530259A5 (enExample)
JP2019510787A5 (enExample)
JP2003128673A5 (enExample)
JP2013532652A5 (enExample)
MX2011002348A (es) Terapia de combinacion para tuberculosis.
HU229935B1 (en) Dual action antibiotics
JP2019527724A5 (enExample)
JP2007514691A5 (enExample)
JP2013542267A5 (enExample)
JP2020097577A5 (enExample)
RU2007101653A (ru) Производные 1-азабицикло[3.3.1]нонанов
JP2011526247A5 (enExample)
JP2021501756A5 (enExample)
JP2019520344A5 (enExample)
JP2011509302A5 (enExample)
JP2008513485A5 (enExample)
JPWO2021030556A5 (enExample)